• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 56,756.00
    -196.75 (--0.35%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,482.00(%)
  • One 97
    1,090.00 1,063.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 752.50(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 193.15(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 209.10(%)
  • St Bk of India
    825.00 895.30(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Tata Motors
    692.95 1,179.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Balaxi Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 22472.0
  • ISIN : INE618N01022
48.92 0 (-0.18%)
  • As on 23 Jul 2025 (EOD)

  • Today’s Low

    48.75

  • Today’s High

    49.50

  • Open

    49.50

  • Perv Close

    49.01

  • 52W Low

    48.53

  • 52W High

    129.44

Key Indicators

  • P/E(TTM)

    75.26

  • Mar.Cap (₹Cr.)

    270.08

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.16

  • Debt-Equity Ratio

    -0.18

  • AGM Date

    22-Jul-2025

  • EPS

    0.65

  • P/E Ratio

    75.26

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    270.08

  • RONW (%)

    -25.94

  • ROCE (%)

    20.69

Score Board

  • Equity (₹ in Cr.)

    11.04

  • BV (₹)

    23.20

  • Sales( ₹ in Cr.)

    60.99

  • NP (in Cr.)

    3.60

  • NP Var(%)

    -2.0

  • Div%

    0.0

  • CPS (₹)

    0.70

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    270.08

  • 52 Week High

    129.44

  • 52 Week Low

    48.53

  • Price BSE

    0.0

  • Price NSE

    49.00

  • Market Capital( in Cr.)

    270.08

  • P/C Ratio

    66.70

  • P/E Ratio

    75.10

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 70.20 108.14 101.29 86.87 45.63 13.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 70.20 108.14 101.29 86.87 45.63 13.60
Other Income 2.40 6.60 2.75 1.81 0.59 0.89
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 72.60 114.74 104.04 88.68 46.22 14.49
EXPENDITURE :            
Raw Materials 56.49 82.10 76.92 63.33 32.83 0.00
Power and Fuel Cost 0.04 0.04 0.02 0.00 0.00 0.00
Employee Cost 5.04 4.04 2.90 1.95 1.75 0.90
Other Manufacturing Expenses 0.21 0.25 0.13 0.12 0.00 10.30
Selling and Administration Expenses 2.58 4.51 3.79 2.06 1.71 0.59
Miscellaneous Expenses 0.49 0.33 0.23 0.39 0.69 0.25
Employee Benefit Expenses 5.04 4.04 2.90 1.95 1.75 0.90
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 64.84 91.27 83.99 67.85 36.99 12.04
Operating Profit 7.75 23.48 20.05 20.83 9.24 2.44
Interest 1.66 0.51 0.10 0.15 0.05 0.00
Gross Profit 6.09 22.97 19.95 20.68 9.19 2.44
Depreciation 0.51 0.52 0.25 0.09 0.01 0.00
Profit Before Tax 5.58 22.45 19.70 20.59 9.18 2.44
Current Tax 2.04 5.17 5.00 5.46 2.69 0.47
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.11 1.06 0.03 0.00 0.00 0.00
Reported Net Profit 3.65 16.22 14.67 15.13 6.50 1.97
Extraordinary Items -0.04 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.69 16.22 14.67 15.13 6.50 1.97
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 52.34 36.61 21.95 6.81 0.32 -1.65
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.50 0.00 0.00 0.00 0.00
P & L Balance carried down 55.99 52.34 36.61 21.95 6.81 0.32
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 5.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.50 0.00 0.00 0.00
Earnings Per Share-Unit Curr 3.35 15.93 14.67 15.13 6.50 6.47
Earnings Per Share(Adj)-Unit Curr 0.67 3.19 2.93 3.03 1.30 1.29
Book Value 108.07 80.35 57.91 43.25 28.11 11.58
Book Value(Adj)-Unit Curr 21.61 16.07 11.58 8.65 5.62 2.32

Shareholding Pattern

  • Promoter Group

    65.99%

  • Public Share Holding

    34.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 35,000,000 63.40 35,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,431,770 2.59 1,431,770 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 36,431,770 65.99 36,431,770 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 13,160 0.02 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,846,446 16.02 8,846,446 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,859,606 16.05 8,846,446 4
2] Non Institution
Bodies Corporate 1,978,359 3.58 1,978,359 44
Clearing Members 50 0.00 50 1
Directors of their Relatives 1,068,795 1.94 1,068,795 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 183,494 0.33 183,494 95
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 98,781 0.18 98,781 118
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,499,663 2.72 1,499,663 5
Individuals holding nominal share capital up to Rs. 1 lakh 3,920,226 7.10 3,782,776 9,720
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,166,756 2.11 1,166,756 2
Sub Total 9,916,124 17.96 9,778,674 9,987
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 55,207,500 100.00 55,056,890 9,994

Company Background

Balaxi Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Balaxi Pharmaceuticals Ltd
  • BSE Code : 22472.0
  • ISIN : INE618N01022

  • Incorporation Year

    1942

  • Registered Office

    41/298-D2 2nd Flr Saniya Plaza
    Mahakavi Bharatiyar Road, Cochin,
    Kerala-682035

  • Telephone

    91-484-4032952/6596725

  • FAX

  • Chairman

  • Managing Director

    Ashish Maheshwari

  • Company Secretary

    Mohith Kumar Khandelwal

  • Auditor

    P Murali & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    SKDC Consultants Ltd
    Surya 35 Mayflower ,
    Avenue Sowripalayam ,Road
    Mumbai - Coimbatore - 641 028

Balaxi Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Balaxi Pharma 48.92 72.59 70.20 75.26 5.99
Abbott India 34,192.50 6,684.73 6,409.15 51.37 44.95
Astrazeneca Phar 9,002.30 1,330.33 1,295.53 194.43 33.26
P & G Health Ltd 5,861.90 1,166.89 1,151.26 38.74 39.76
Glaxosmi. Pharma 3,098.40 3,866.05 3,723.49 57.11 58.72
Cipla 1,465.00 20,029.57 19,044.85 22.94 21.40
Amrutanjan Healt 699.55 437.58 421.23 39.79 20.84
Fermenta Biotec. 386.95 442.21 430.53 16.85 17.61
Guj. Themis Bio. 372.80 174.19 169.82 83.21 44.82
Bliss GVS Pharma 158.55 703.42 667.20 24.24 9.16
Ambalal Sarabhai 35.11 19.33 4.04 32.51 2.10